Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity.

Liang L, Cui C, Lv D, Li Y, Huang L, Feng J, An T, Tian P, Yang K, Hu L, Gao L, Zhang J, Zhang Y, Ma F, Wang Y

Open source

DOI
10.1002/ehf2.14340
Published
2023 Jun
Container
ESC heart failure
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ehf2.14340,
  title = {Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity.},
  author = {Liang L and Cui C and Lv D and Li Y and Huang L and Feng J and An T and Tian P and Yang K and Hu L and Gao L and Zhang J and Zhang Y and Ma F and Wang Y},
  year = {2023},
  journal = {ESC heart failure},
  doi = {10.1002/ehf2.14340},
  url = {https://doi.org/10.1002/ehf2.14340}
}

RIS

TY  - JOUR
TI  - Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity.
AU  - Liang L
AU  - Cui C
AU  - Lv D
AU  - Li Y
AU  - Huang L
AU  - Feng J
AU  - An T
AU  - Tian P
AU  - Yang K
AU  - Hu L
AU  - Gao L
AU  - Zhang J
AU  - Zhang Y
AU  - Ma F
AU  - Wang Y
PY  - 2023
JO  - ESC heart failure
DO  - 10.1002/ehf2.14340
UR  - https://doi.org/10.1002/ehf2.14340
ER  - 

APA

L, L., C, C., D, L., Y, L., L, H., J, F., T, A., P, T., K, Y., L, H., L, G., J, Z., Y, Z., F, M., & Y, W. (2023). Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity.. ESC heart failure. https://doi.org/10.1002/ehf2.14340

Source records